Here are some of the drugs that are predicted to become blockbusters in the next few years, according to Clarivate's latest ...

Recently, Viva Biotech's portfolio companies have new updates: TechnoDerma, VivaVision, Arthrosi, Apeiron Therapeutics and AceLink made solid progress in R&D; Full Circles published breakthrough ...